sur BIOSYNEX (EPA:ALBIO)
Brigitte Geny resigns from the Board of Directors of BIOSYNEX
On December 30, 2025, the Board of Directors of BIOSYNEX announced the resignation of Ms. Brigitte Geny from her position as an independent director for personal reasons. Her departure will take effect on January 19, 2026, thus reducing the number of directors to six.
The Board expressed its gratitude to Ms. Geny for her commitment and contribution to the Board's work. This transition comes as the company prepares its upcoming financial communications, including the announcement of its 2025 annual revenue scheduled for January 15, 2026.
BIOSYNEX, based in Alsace, is a major player in the rapid diagnostic testing sector, developing and marketing innovative solutions worldwide. The company continues to expand its international reach through a dynamic growth strategy.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BIOSYNEX